We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.

Key Record Dates

ClinicalTrials.gov Identifier: NCT05082610
Brief Title: A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab

First Submitted : September 21, 2021
First Submitted that Met QC Criteria : October 14, 2021
First Posted : October 19, 2021

Last Update Submitted that Met QC Criteria : April 27, 2023
Last Update Posted : May 1, 2023